Current and Future Insights in H. pylori Eradication Regimens: The Need of Tailoring Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|28|4521-4532

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.28, 2014-08, pp. : 4521-4532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

H. pylori eradication therapy: new regimens effective

By  

Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Levofloxacin-based regimens lead the way in H. pylori eradication

By  

Inpharma, Vol. 1, Iss. 1513, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Helicobacter pylori Eradication Regimens: Is there a Difference?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 3, 2010-09 ,pp. : 194-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost reductions with H. pylori eradication prior to NSAID therapy

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Second-line quadruple therapy effective for H. pylori eradication

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite